Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul 18:2018:8296139.
doi: 10.1155/2018/8296139. eCollection 2018.

Association between Participants' Characteristics, Patient-Reported Outcomes, and Clinical Outcomes in Youth with Sickle Cell Disease

Sherif M Badawy  1   2 , Leonardo Barrera  2 , Stephanie Cai  3 , Alexis A Thompson  1   2
Affiliations

Association between Participants' Characteristics, Patient-Reported Outcomes, and Clinical Outcomes in Youth with Sickle Cell Disease

Sherif M Badawy et al. Biomed Res Int. .

Abstract

Background: Sickle cell disease (SCD) is a chronic debilitating illness. SCD-related complications result in substantial impairment in quality of life (QOL). Our study objective was to assess the relationship of participants' characteristics, QOL, hydroxyurea adherence, and SCD-related clinical outcomes in youth with SCD.

Procedure: A single-center cross-sectional study. Thirty-four youth with SCD enrolled from clinic between January and December 2015. Participants completed PROMIS® measures and ©Modified Morisky Adherence Scale.

Results: Participants had a mean age of 14.8 (SD 2.9) years and 41% were female. Participants' age correlated with fatigue (rs=0.48; P=0.006), pain (rs=0.32; P=0.07), and anxiety (rs=0.33; P=0.06) scores. Participants with chronic pain had worse upper extremity physical function (P=0.05), pain (P=0.04), anxiety (P=0.05), and depression (P=0.05). Males reported significantly higher hydroxyurea adherence (5.4 versus 3.6, P=0.02) compared to females. Participants with chronic pain had more frequent hospitalizations (P=0.02), emergency room visits (P=0.04), and longer total length of hospital stays over 12-month period (P=0.01).

Conclusions: Older and female participants had worse QOL scores, and males reported higher hydroxyurea adherence. Participants with chronic pain reported significant impairment in different QOL domains and had increased healthcare utilization. Future longitudinal studies examining the relationship between participants' characteristics, QOL, hydroxyurea adherence, and SCD-related clinical outcomes are needed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Participants' PROMIS® quality of life scores across different domains (T scores, median and interquartile range).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Piel F. B., Patil A. P., Howes R. E., et al. Global epidemiology of Sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. The Lancet. 2013;381(9861):142–151. doi: 10.1016/s0140-6736(12)61229-x. - DOI - PMC - PubMed
    1. National Heart, Lung and Blood Institute. What Is Sickle Cell Anemia?, 2012, http://www.nhlbi.nih.gov/health/health-topics/topics/sca/
    1. Piel F. B., Steinberg M. H., Rees D. C. Sickle cell disease. The New England Journal of Medicine. 2017;376(16):1561–1573. doi: 10.1056/NEJMra1510865. - DOI - PubMed
    1. Panepinto J. A., Bonner M. Health- quality of life in sickle cell disease: Past, present, and future. Pediatric Blood & Cancer. 2012;59(2):377–385. doi: 10.1002/pbc.24176. - DOI - PubMed
    1. Panepinto J. A., Torres S., Bendo C. B., et al. PedsQL™ multidimensional fatigue scale in sickle cell disease: Feasibility, reliability, and validity. Pediatric Blood & Cancer. 2014;61(1):171–177. doi: 10.1002/pbc.24776. - DOI - PMC - PubMed